These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38753224)
1. Perinatal Use and Discontinuation of Disease-Modifying Antirheumatic Drugs: Outcomes of Patients Seen at a Pregnancy and Rheumatic Diseases Clinic. Rebić N; De Vera MA; Gupta A; Amiri N J Clin Rheumatol; 2024 Aug; 30(5):188-192. PubMed ID: 38753224 [TBL] [Abstract][Full Text] [Related]
2. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases. N MS; Álvarez-Troncoso J; Robles-Marhuenda Á; De la Calle Fernández-Miranda M; Muner Hernando ML; Bartha JL J Autoimmun; 2024 Sep; 148():103301. PubMed ID: 39141986 [TBL] [Abstract][Full Text] [Related]
3. Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study. Rebić N; Sayre EC; Zusman EZ; Amiri N; Baldwin C; De Vera MA Rheumatology (Oxford); 2020 Jul; 59(7):1514-1521. PubMed ID: 31628479 [TBL] [Abstract][Full Text] [Related]
4. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Ostensen M; Ramsey-Goldman R Drug Saf; 1998 Nov; 19(5):389-410. PubMed ID: 9825952 [TBL] [Abstract][Full Text] [Related]
5. Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study. Howren A; Rebić N; Sayre EC; Tsao NW; Amiri N; Baldwin C; De Vera MA Clin Exp Rheumatol; 2020; 38(6):1080-1087. PubMed ID: 32141437 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. van den Brandt S; Zbinden A; Baeten D; Villiger PM; Østensen M; Förger F Arthritis Res Ther; 2017 Mar; 19(1):64. PubMed ID: 28320445 [TBL] [Abstract][Full Text] [Related]
7. Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases. Brites L; Madeira N; Rodrigues J; Marona J; Martins N; Águeda A; Freitas R; Neto A; Capela S; Sequeira G; Ganhão S; Duarte C; Santiago M; Santos MJ Acta Reumatol Port; 2019; 44(4):266-272. PubMed ID: 32008032 [TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Bermas BL Curr Opin Rheumatol; 2014 May; 26(3):334-40. PubMed ID: 24663106 [TBL] [Abstract][Full Text] [Related]
9. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC; Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903 [TBL] [Abstract][Full Text] [Related]
10. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948 [TBL] [Abstract][Full Text] [Related]
11. Lactation and Management of Postpartum Disease. Bermas BL Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567 [TBL] [Abstract][Full Text] [Related]
12. Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology. Manara M; Bruno D; Ferrito M; Perniola S; Caporali RF; Gremese E Reumatismo; 2024 Sep; 76(3):. PubMed ID: 39282774 [TBL] [Abstract][Full Text] [Related]
13. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Levy RA; de Jesús GR; de Jesús NR; Klumb EM Autoimmun Rev; 2016 Oct; 15(10):955-63. PubMed ID: 27490204 [TBL] [Abstract][Full Text] [Related]
14. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study. Andreoli L; Gerardi MC; Gerosa M; Rozza D; Crisafulli F; Erra R; Lini D; Trespidi L; Padovan M; Ruffilli F; Serale F; Cuomo G; Raffeiner B; Semeraro P; Tani C; Chimenti MS; Conigliaro P; Hoxha A; Nalli C; Fredi M; Lazzaroni MG; Filippini M; Taglietti M; Franceschini F; Zatti S; Loardi C; Orabona R; Ramazzotto F; Zanardini C; Fontana G; Gozzoli G; Barison C; Bizioli P; Caporali RF; Carrea G; Ossola MW; Maranini B; Silvagni E; Govoni M; Morano D; Verteramo R; Doria A; Del Ross T; Favaro M; Calligaro A; Tonello M; Larosa M; Zen M; Zambon A; Mosca M; Zucchi D; Elefante E; Gori S; Iannone F; Anelli MG; Lavista M; Abbruzzese A; Fasano CG; D'Angelo S; Cutro MS; Picerno V; Carbone T; Padula AA; Rovere-Querini P; Canti V; De Lorenzo R; Cavallo L; Ramoni V; Montecucco C; Codullo V; Milanesi A; Pazzola G; Comitini G; Marvisi C; Salvarani C; Epis OM; Benedetti S; Di Raimondo G; Gagliardi C; Lomater C; Crepaldi G; Bellis E; Bellisai F; Garcia Gonzalez E; Pata AP; Zerbinati M; Urban ML; Mattioli I; Iuliano A; Sebastiani G; Brucato AL; Bizzi E; Cutolo M; Santo L; Tonetta S; Landolfi G; Carrara G; Bortoluzzi A; Scirè CA; Tincani A; RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663885 [TBL] [Abstract][Full Text] [Related]
15. No excess risks in offspring with paternal preconception exposure to disease-modifying antirheumatic drugs. Wallenius M; Lie E; Daltveit AK; Salvesen KÅ; Skomsvoll JF; Kalstad S; Lexberg ÅS; Mikkelsen K; Kvien TK; Østensen M Arthritis Rheumatol; 2015 Jan; 67(1):296-301. PubMed ID: 25418443 [TBL] [Abstract][Full Text] [Related]
16. Optimisation of antirheumatic drug treatment in pregnancy. Ostesen M Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637 [TBL] [Abstract][Full Text] [Related]
17. Disease-modifying anti-rheumatic drug use in pregnant women with rheumatic diseases: a systematic review of the risk of congenital malformations. Baldwin C; Avina-Zubieta A; Rai SK; Carruthers E; De Vera MA Clin Exp Rheumatol; 2016; 34(2):172-83. PubMed ID: 26940667 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy and rheumatic disease: "by the book" or "by the doc". Keeling SO; Oswald AE Clin Rheumatol; 2009 Jan; 28(1):1-9. PubMed ID: 18987777 [TBL] [Abstract][Full Text] [Related]
19. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Flint J; Panchal S; Hurrell A; van de Venne M; Gayed M; Schreiber K; Arthanari S; Cunningham J; Flanders L; Moore L; Crossley A; Purushotham N; Desai A; Piper M; Nisar M; Khamashta M; Williams D; Gordon C; Giles I; Rheumatology (Oxford); 2016 Sep; 55(9):1693-7. PubMed ID: 26750124 [No Abstract] [Full Text] [Related]
20. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study. Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]